The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.127.3.368

There has been an increasing number of sudden deaths in psychotic patients taking phenothiazines. The authors present a case report that they believe offers some insight into why such deaths occur. They feel that the combination of vasodilatation with the hypotensive effects of phenothiazines might explain some of the unexpected deaths.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.